Adipotide vs NAD+ — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...
Calculate Adipotide dose →NAD+ is a coenzyme present in every cell, essential for mitochondrial ATP production via electron transport, DNA repair via PARP enzymes, and sirtuin deacetylase activation. Levels decline approximately 50% between age 20 and 60. Restored through IV therapy or oral precursors NMN...
Calculate NAD+ dose →| Parameter | Adipotide | NAD+ |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | Widely Studied |
| Half-Life | - | Very short (direct IV); precursors have hours-long kinetics |
| Typical Dose | 1 mg/kg body weight | 250–1,000 mg (IV) |
| Frequency | Daily (research cycles) | 2–3x weekly (IV therapy); daily (oral precursors) |
| Route | Subcutaneous | IV / IM / Oral (as precursors NMN, NR) |
| FDA Status | Not Approved | Not Approved (drug use) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.